Phase I and pharmacokinetic study of low-dose, three-times daily oral etoposide in patients with refractory solid tumors

被引：0
|
作者：
Schwartsmann, G
Di Leone, L
Caldas, APF
Campos, O
Cancela, AI
Viegas, MAV
Mans, DRA
机构：
[1] UFRGS, HCPA, S Amer Off Anticanc Drug Dev SOAD, Porto Alegre, RS, Brazil
[2] ULBRA, Lutheran Hosp, Porto Alegre, RS, Brazil
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
660
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [31] A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas
    Gore, Lia
    Rothenberg, Mace L.
    O'Bryant, Cindy L.
    Schultz, Mary Kay
    Sandler, Alan B.
    Coffin, Denise
    McCoy, Candice
    Schott, Astrid
    Scholz, Catherine
    Eckhardt, S. Gail
    CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4517 - 4525
  • [32] Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors
    Needle, MN
    Molloy, PT
    Geyer, JR
    HermanLiu, A
    Belasco, JB
    Goldwein, JW
    Sutton, L
    Phillips, PC
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 29 (01): : 28 - 32
  • [33] Cefixime allows greater dose escalation of oral irinotecan: A phase I study in pediatric patients with refractory solid tumors
    Furman, WL
    Crews, KR
    Billups, C
    Wu, JR
    Gajjar, AJ
    Daw, NC
    Patrick, CC
    Rodriguez-Galindo, C
    Stewart, CF
    Dome, JS
    Panetta, JC
    Houghton, PJ
    Santana, VM
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 563 - 570
  • [34] Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors
    McGregor, Lisa M.
    Stewart, Clinton F.
    Crews, Kristine R.
    Tagen, Michael
    Wozniak, Amy
    Wu, Jianrong
    McCarville, M. Beth
    Navid, Fariba
    Santana, Victor M.
    Houghton, Peter J.
    Furman, Wayne L.
    Galindo, Carlos Rodriguez
    PEDIATRIC BLOOD & CANCER, 2012, 58 (03) : 372 - 379
  • [35] Phase I study of bevacizumab, sorafenib, and low-dose cyclophosphamide (CYC) in children and young adults with refractory solid tumors.
    Santana, V. M.
    Baker, S. D.
    McCarville, B.
    Stewart, C. F.
    Wu, J.
    Billups, C.
    Spunt, S. L.
    Furman, W. L.
    McGregor, L. M.
    Hu, S.
    Panetta, J. C.
    Reddick, W. E.
    Davidoff, A.
    Leung, W. H.
    Navid, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors
    Stewart, Clinton F.
    Tagen, Michael
    Schwartzberg, Lee S.
    Blakely, L. Johnetta
    Tauer, Kurt W.
    Smiley, Linda M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (03) : 561 - 568
  • [37] Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors
    Clinton F. Stewart
    Michael Tagen
    Lee S. Schwartzberg
    L. Johnetta Blakely
    Kurt W. Tauer
    Linda M. Smiley
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 561 - 568
  • [38] Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
    Demetri, George D.
    Lo Russo, Patricia
    MacPherson, Lain R. J.
    Wang, Ding
    Morgan, Jeffrey A.
    Brunton, Valerie G.
    Paliwal, Prashni
    Agrawal, Shruti
    Voi, Maurizio
    Evan, T. R. Jeffry
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6232 - 6240
  • [39] Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors
    Overman, Michael J.
    Kopetz, Scott
    Varadhachary, Gauri
    Fukushima, Masakazu
    Kuwata, Keizo
    Mita, Akira
    Wolff, Robert A.
    Hoff, Paulo
    Xiong, Henry
    Abbruzzese, James L.
    CANCER INVESTIGATION, 2008, 26 (08) : 794 - 799
  • [40] Phase I Trial and Pharmacokinetic Study of Ixabepilone Administered Daily for 5 Days in Children and Adolescents With Refractory Solid Tumors
    Widemann, Brigitte C.
    Goodspeed, Wendy
    Goodwin, Anne
    Fojo, Tito
    Balis, Frank M.
    Fox, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 550 - 556
12345